IMMUNETHEP
Cantanhede
About IMMUNETHEP
Immunethep is a biotechnology company focused on drug development for Immune System related pathologies. Immunethep is a spin-off from the University of Porto that uses its proprietary technology to address unmet medical needs. Immunethep discovered a novel mechanism used by different pathogenic bacteria to suppress host immune response. By targeting this mechanism we are developing broad coverage anti-bacterial immunotherapies.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $3.8M
- Last round: Grant (Mar 2025)
- Website: immunethep.com
- Phone: +351231419042
Industries & Categories
Biotechnology, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/immunethep-121370 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.